Nifty
:
24273.80
Sensex
:
80334.81
-140.60 (-0.58%)
-411.97 (-0.51%)
Nifty
Sensex
:
:
24273.80
80334.81
-140.60 (-0.58%)
-411.97 (-0.51%)

Nureca Ltd.

Medical Equipment/Supplies/Accessories

Rating :
N/A

BSE: 543264 | NSE: NURECA

NSE BSE
282.75
06-Feb-2025
  • Open
  • High
  • Low
  • Previous Close
  •  288.90
  •  288.90
  •  281.05
  •  287.15
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  7740
  •  22.10
  •  447.50
  •  203.62

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 238.00
  • 281.33
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 194.12
  • N/A
  • 1.23

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 64.30%
  • 0.63%
  • 32.39%
  • FII
  • DII
  • Others
  • 1.07%
  • 0.00%
  • 1.61%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -1.56
  • -28.88

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 2.25

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 169.18

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Var%
Dec 24
Dec 23
Var%
Sep 24
Sep 23
Var%
Jun 24
Jun 23
Var%
Net Sales
31.74
16.97
87.04%
26.46
22.37
18.28%
31.19
31.35
-0.51%
20.27
21.23
-4.52%
Expenses
30.54
21.40
42.71%
30.48
26.63
14.46%
33.55
29.97
11.95%
22.64
24.13
-6.17%
EBITDA
1.20
-4.43
-
-4.01
-4.25
-
-2.36
1.38
-
-2.37
-2.90
-
EBIDTM
3.78%
-26.13%
-15.17%
-19.02%
-7.56%
4.42%
-11.69%
-13.67%
Other Income
1.99
-1.26
-
1.48
5.90
-74.92%
3.17
3.20
-0.94%
5.79
2.67
116.85%
Interest
0.62
0.18
244.44%
0.18
0.11
63.64%
0.27
0.08
237.50%
0.15
0.12
25.00%
Depreciation
0.52
0.60
-13.33%
0.54
0.59
-8.47%
0.62
0.59
5.08%
0.66
0.58
13.79%
PBT
2.05
-6.47
-
-3.25
0.95
-
-0.08
3.91
-
2.62
-0.93
-
Tax
-0.42
-2.33
-
-0.45
0.78
-
0.41
1.02
-59.80%
0.96
-0.22
-
PAT
2.47
-4.15
-
-2.80
0.16
-
-0.48
2.89
-
1.66
-0.71
-
PATM
7.77%
-24.43%
-10.58%
0.74%
-1.55%
9.23%
8.20%
-3.33%
EPS
2.47
-4.15
-
-2.80
0.17
-
-0.48
2.89
-
1.66
-0.71
-

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Net Sales
109.66
91.93
111.32
255.55
213.45
99.43
61.90
20.05
Net Sales Growth
19.30%
-17.42%
-56.44%
19.72%
114.67%
60.63%
208.73%
 
Cost Of Goods Sold
68.01
60.61
75.53
132.62
99.48
64.60
40.15
11.11
Gross Profit
41.65
31.31
35.79
122.92
113.97
34.82
21.74
8.94
GP Margin
37.98%
34.06%
32.15%
48.10%
53.39%
35.02%
35.12%
44.59%
Total Expenditure
117.21
102.16
126.33
200.04
151.91
89.73
52.84
15.68
Power & Fuel Cost
-
0.13
0.20
0.16
0.01
0.04
0.02
0.01
% Of Sales
-
0.14%
0.18%
0.06%
0.00%
0.04%
0.03%
0.05%
Employee Cost
-
12.20
16.06
9.91
4.58
3.16
0.89
0.36
% Of Sales
-
13.27%
14.43%
3.88%
2.15%
3.18%
1.44%
1.80%
Manufacturing Exp.
-
0.65
0.91
0.00
0.00
0.00
0.00
0.00
% Of Sales
-
0.71%
0.82%
0%
0%
0%
0%
0%
General & Admin Exp.
-
5.75
7.94
9.42
3.11
3.38
0.52
0.23
% Of Sales
-
6.25%
7.13%
3.69%
1.46%
3.40%
0.84%
1.15%
Selling & Distn. Exp.
-
19.21
22.45
43.68
43.32
17.94
10.63
3.91
% Of Sales
-
20.90%
20.17%
17.09%
20.30%
18.04%
17.17%
19.50%
Miscellaneous Exp.
-
3.60
3.24
4.25
1.42
0.62
0.64
0.06
% Of Sales
-
3.92%
2.91%
1.66%
0.67%
0.62%
1.03%
0.30%
EBITDA
-7.54
-10.23
-15.01
55.51
61.54
9.70
9.06
4.37
EBITDA Margin
-6.88%
-11.13%
-13.48%
21.72%
28.83%
9.76%
14.64%
21.80%
Other Income
12.43
10.53
7.11
7.70
2.82
0.06
0.09
0.02
Interest
1.22
0.49
0.45
0.74
1.60
0.77
0.24
0.06
Depreciation
2.34
2.36
2.39
1.48
0.42
0.37
0.06
0.01
PBT
1.34
-2.54
-10.74
60.98
62.33
8.61
8.84
4.32
Tax
0.50
-0.75
-2.49
16.02
15.96
2.21
2.62
1.21
Tax Rate
37.31%
29.53%
23.18%
26.27%
25.61%
25.67%
29.64%
28.01%
PAT
0.85
-1.79
-8.25
44.96
46.37
6.39
6.23
3.11
PAT before Minority Interest
0.85
-1.79
-8.25
44.96
46.37
6.39
6.23
3.11
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
0.78%
-1.95%
-7.41%
17.59%
21.72%
6.43%
10.06%
15.51%
PAT Growth
146.96%
-
-
-3.04%
625.67%
2.57%
100.32%
 
EPS
0.85
-1.79
-8.25
44.96
46.37
6.39
6.23
3.11

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Shareholder's Funds
193.11
194.88
203.20
163.10
14.94
7.95
1.72
Share Capital
10.00
10.00
10.00
10.00
0.01
0.01
0.01
Total Reserves
183.11
184.88
193.20
153.10
13.93
6.95
0.72
Non-Current Liabilities
-2.12
0.09
3.59
3.23
9.40
0.28
0.01
Secured Loans
0.33
0.00
0.00
0.00
0.00
0.00
0.00
Unsecured Loans
0.00
0.00
0.00
0.78
9.35
0.26
0.00
Long Term Provisions
0.98
0.79
0.41
0.45
0.10
0.03
0.01
Current Liabilities
9.27
8.88
45.27
23.95
9.51
15.29
5.29
Trade Payables
5.17
4.99
4.72
8.74
5.83
9.76
5.26
Other Current Liabilities
3.01
3.51
5.21
5.39
1.23
5.51
0.02
Short Term Borrowings
0.08
0.08
0.08
0.22
0.08
0.00
0.00
Short Term Provisions
1.00
0.30
35.26
9.59
2.38
0.02
0.01
Total Liabilities
200.26
203.85
252.06
190.28
33.85
23.52
7.02
Net Block
7.11
8.65
10.19
3.68
1.06
0.54
0.02
Gross Block
11.41
10.59
11.87
3.89
1.14
0.61
0.03
Accumulated Depreciation
4.30
1.94
1.69
0.20
0.08
0.06
0.01
Non Current Assets
7.67
17.29
12.84
4.08
1.09
0.55
0.02
Capital Work in Progress
0.27
0.00
0.42
0.30
0.00
0.00
0.00
Non Current Investment
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Loans & Adv.
0.29
1.40
0.27
0.10
0.03
0.00
0.00
Other Non Current Assets
0.00
7.24
1.95
0.00
0.00
0.00
0.00
Current Assets
192.59
186.56
239.23
186.20
32.76
22.97
7.00
Current Investments
93.63
59.09
33.19
0.00
0.00
0.00
0.00
Inventories
30.85
34.48
63.18
36.78
16.43
13.55
3.54
Sundry Debtors
1.61
4.29
2.89
0.22
12.90
8.86
1.69
Cash & Bank
45.30
70.97
84.35
126.69
0.07
0.11
0.07
Other Current Assets
21.19
3.91
7.62
6.58
3.36
0.46
1.70
Short Term Loans & Adv.
17.10
13.83
47.99
15.93
1.36
0.45
1.69
Net Current Assets
183.32
177.68
193.96
162.25
23.25
7.68
1.70
Total Assets
200.26
203.85
252.07
190.28
33.85
23.52
7.02

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Cash From Operating Activity
-2.71
10.23
1.40
34.87
-7.92
0.31
0.10
PBT
-2.54
-10.74
60.98
62.33
8.61
8.84
4.32
Adjustment
-6.76
-3.48
-3.73
0.11
1.17
0.30
0.03
Changes in Working Capital
5.34
28.59
-37.90
-12.51
-17.69
-8.83
-4.26
Cash after chg. in Working capital
-3.96
14.37
19.35
49.93
-7.92
0.31
0.10
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
1.25
-4.15
-17.95
-15.07
-0.01
-0.01
0.00
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
17.58
-16.46
-3.09
-110.04
-0.39
-0.12
-0.02
Net Fixed Assets
-0.50
1.96
-7.96
-2.72
-1.08
-0.06
Net Investments
-34.54
-27.65
-33.68
-0.77
-0.05
0.00
Others
52.62
9.23
38.55
-106.55
0.74
-0.06
Cash from Financing Activity
-1.30
-1.51
-7.30
92.34
8.28
-0.14
-0.06
Net Cash Inflow / Outflow
13.56
-7.74
-8.99
17.17
-0.04
0.04
0.02
Opening Cash & Equivalents
0.50
8.25
17.24
0.07
0.11
0.07
0.05
Closing Cash & Equivalent
14.06
0.50
8.25
17.24
0.07
0.11
0.07

Financial Ratios

Standalone /

Consolidated
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Book Value (Rs.)
193.11
194.88
203.20
163.10
1990.71
6955.00
730.00
ROA
-0.89%
-3.62%
20.33%
41.38%
22.30%
40.78%
44.35%
ROE
-0.92%
-4.14%
24.55%
52.39%
61.23%
162.03%
426.30%
ROCE
-1.06%
-5.17%
33.57%
67.61%
56.70%
179.97%
255.06%
Fixed Asset Turnover
9.09
10.38
34.28
89.50
113.76
201.42
771.19
Receivable days
10.79
11.25
2.11
10.64
39.93
30.18
30.69
Inventory Days
119.26
152.88
67.53
43.16
55.02
48.92
64.42
Payable days
30.60
23.46
18.53
26.74
31.96
44.39
103.55
Cash Conversion Cycle
99.45
140.67
51.10
27.07
62.99
34.71
-8.44
Total Debt/Equity
0.00
0.00
0.00
0.01
0.70
0.06
0.00
Interest Cover
-4.20
-22.87
83.30
39.89
12.14
37.38
68.55

Top Investors:

nisarg vakharia

Annual Reports:

FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019

News Update:


  • Nureca expands quick commerce reach with Dr Trust products now available on Swiggy Instamart
    30th Apr 2025, 11:41 AM

    Dr Trust products are already available on Blinkit and Zepto, and are now accessible across all major instant delivery platforms in India

    Read More
  • Nureca gets nod to set up new manufacturing facility in Punjab
    22nd Apr 2025, 12:20 PM

    This unit will focus on the manufacturing of health and wellness equipment

    Read More
  • Nureca’s manufacturing arm completes annual registration with USFDA
    14th Apr 2025, 09:09 AM

    This registration authorizes Nureca Technologies to continue manufacturing and exporting a suite of medical devices to the United States

    Read More
  • Nureca gets nod to purchase land in India
    25th Feb 2025, 12:12 PM

    The Board of Directors of the company at the meeting held on February 24, 2025, has approved the same

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.